# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4419969 | F | Inhibition of adherence-independent cell growth in human NCI-H1650 cells at 5 uM incubated for 33 days | Homo sapiens | 5 | cell-based format | Patent Bioactivity Data | ||
2. | ALA4419970 | F | Inhibition of adherence-independent cell growth in human NCI-H1650 cells at 10 uM incubated for 33 days | Homo sapiens | 5 | cell-based format | Patent Bioactivity Data | ||
3. | ALA4419974 | F | Inhibition of self-renewal capacity in methotrexate insensitive stem-like side-population cells of human NCI-H146 cells assessed as reduction in number of spheres at 2 uM incubated for 3 days after 7 days methotrexate exposure by sphere formation assay | Homo sapiens | 6 | assay format | Patent Bioactivity Data | ||
4. | ALA4419977 | F | Cytotoxicity in gefitinib and erlotinib resistant human NCI-H1975 cells assessed as reduction in cell viability at 1 to 10 uM incubated for 72 hrs by MTT assay | Homo sapiens | 5 | cell-based format | Patent Bioactivity Data | ||
5. | ALA4419978 | B | Inhibition of YAP1 in human NCI-H1650 cells assessed as suppression of Sox2 mRNA expression at 5 to 10 uM incubated for 72 hrs by RT-PCR method | Homo sapiens | 5 | cell-based format | Patent Bioactivity Data | ||
6. | ALA4419979 | B | Inhibition of YAP1 in human NCI-H1703 cells assessed as suppression of Sox2 mRNA expression at 5 to 10 uM incubated for 72 hrs by RT-PCR method | Homo sapiens | 5 | cell-based format | Patent Bioactivity Data | ||
7. | ALA4419980 | B | Inhibition of YAP1 in human NCI-H146 cells assessed as suppression of Sox2 mRNA expression at 5 to 10 uM incubated for 72 hrs by RT-PCR method | Homo sapiens | 5 | cell-based format | Patent Bioactivity Data | ||
8. | ALA4419981 | A | Effect on expression of Oct4 mRNA expression in human NCI-H1650 cells at 5 to 10 uM incubated for 72 hrs by RT-PCR method | Homo sapiens | 5 | cell-based format | Patent Bioactivity Data | ||
9. | ALA4419982 | A | Effect on expression of Nanog mRNA expression in human NCI-H1650 cells at 5 to 10 uM incubated for 72 hrs by RT-PCR method | Homo sapiens | 5 | cell-based format | Patent Bioactivity Data | ||
10. | ALA4419983 | A | Effect on expression of Oct4 mRNA expression in human NCI-H1703 cells at 5 to 10 uM incubated for 72 hrs by RT-PCR method | Homo sapiens | 5 | cell-based format | Patent Bioactivity Data | ||
11. | ALA4419984 | A | Effect on expression of Nanog mRNA expression in human NCI-H1703 cells at 5 to 10 uM incubated for 72 hrs by RT-PCR method | Homo sapiens | 5 | cell-based format | Patent Bioactivity Data | ||
12. | ALA4419985 | A | Effect on expression of Oct4 mRNA expression in human NCI-H146 cells at 5 to 10 uM incubated for 72 hrs by RT-PCR method | Homo sapiens | 5 | cell-based format | Patent Bioactivity Data | ||
13. | ALA4419986 | A | Effect on expression of Nanog mRNA expression in human NCI-H146 cells at 5 to 10 uM incubated for 72 hrs by RT-PCR method | Homo sapiens | 5 | cell-based format | Patent Bioactivity Data | ||
14. | ALA4419987 | B | Inhibition of YAP1 in human NCI-H1650 cells assessed as suppression of HK2 mRNA expression at 5 to 10 uM incubated for 72 hrs by RT-PCR method | Homo sapiens | 4 | cell-based format | Patent Bioactivity Data | ||
15. | ALA4419988 | B | Inhibition of YAP1 in human NCI-H1650 cells assessed as suppression of PDK2 mRNA expression at 5 to 10 uM incubated for 72 hrs by RT-PCR method | Homo sapiens | 4 | cell-based format | Patent Bioactivity Data | ||
16. | ALA4419989 | B | Inhibition of YAP1 in human NCI-H1703 cells assessed as suppression of HK2 mRNA expression at 5 to 10 uM incubated for 72 hrs by RT-PCR method | Homo sapiens | 4 | cell-based format | Patent Bioactivity Data | ||
17. | ALA4419990 | B | Inhibition of YAP1 in human NCI-H1703 cells assessed as suppression of PDK2 mRNA expression at 5 to 10 uM incubated for 72 hrs by RT-PCR method | Homo sapiens | 4 | cell-based format | Patent Bioactivity Data | ||
18. | ALA4419991 | B | Inhibition of YAP1 in human NCI-H146 cells assessed as suppression of HK2 mRNA expression at 5 to 10 uM incubated for 72 hrs by RT-PCR method | Homo sapiens | 4 | cell-based format | Patent Bioactivity Data | ||
19. | ALA4419992 | B | Inhibition of YAP1 in human NCI-H146 cells assessed as suppression of PDK2 mRNA expression at 5 to 10 uM incubated for 72 hrs by RT-PCR method | Homo sapiens | 4 | cell-based format | Patent Bioactivity Data | ||
20. | ALA4419993 | B | Inhibition of YAP1 in human NCI-H1650 cells assessed as suppression of PD-L1 mRNA expression at 5 to 10 uM incubated for 72 hrs by RT-PCR method | Homo sapiens | 4 | cell-based format | Patent Bioactivity Data |